Stroke Stem Cell Therapy Development
Stroke is a neurological condition caused by a disruption in blood flow to the brain, leading to brain cell damage. Stem cell therapy is a promising treatment that seeks to harness the regenerative potential of stem cells to repair damaged brain tissue and promote functional recovery. CD BioSciences offers stem cell therapy development services for stroke, based on out advanced technology and professional team.
Introduction into Stroke
A stroke, medically known as a cerebrovascular accident (CVA), is a sudden and often life-altering medical event that affects the brain. It occurs when there is a disruption in the blood supply to a part of the brain, leading to brain cell damage or death. Strokes can have serious and sometimes fatal consequences, making them a critical medical emergency. There are several types of strokes, but the two most common ones are:
Ischemic Stroke
This type of stroke accounts for the majority of cases and occurs when a blood clot or plaque buildup narrows or blocks an artery that supplies blood to the brain.
Hemorrhagic Stroke
This type of stroke happens when a blood vessel in the brain ruptures or leaks, causing bleeding into or around the brain.
Strokes can manifest in various ways, and the symptoms often appear suddenly.
- Sudden numbness or weakness in the face, arm, or leg, especially on one side of the body.
- Sudden confusion, trouble speaking, or difficulty understanding speech.
- Sudden trouble seeing in one or both eyes.
- Sudden severe headache with no known cause.
- Sudden difficulty walking, dizziness, loss of balance, or lack of coordination.
Stem Cell Therapy for Stroke
The unique ability of stem cells to self-renew and differentiate has been exploited to devise cell-based therapies for stroke. Adult stem cells (MSCs and NSC), ESC, and iPSC have assessed for treating stroke. Theoretically, neural stem cells (NSC) are the most suitable cell candidates for nerve repair because they belong to the same tissue origin and have a natural tendency to differentiate into neuronal cells.
Mechanisms of MSCs in treating stroke (Singh, Manisha et al., 2020)
MSCs lead to neural recovery through one or more modes of action, such as release of paracrine factors, cell replacement, and mitochondrial translocation, as well as angiogenic effects. As for iPSC, it's non-immunogenic, easy to access, and non-interventional and not giving rise to ethical concerns.
Our Services
CD BioSciences offers stem cell therapy development service for stroke based on our advanced technology and professional team. Our stem cell therapy development services are performed in stem cells included but not limited as follows:
- Mesenchymal Stem Cells (MSCs)
- Bone Marrow Mononuclear Cells (BM-MNCs)
- Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)
- Bone Marrow Stem Cells (BMSCs)
- Peripheral Blood Stem Cells (PBSCs)
As a pioneer in biotechnology, CD BioSciences has grown into one of the largest independent biotechnology companies in the world. CD BioSciences is committed to providing professional and efficient service to our customers around the world. If you are interested in our service, please contact us.
Reference
- Singh, Manisha et al. "Application of Stem Cells in Stroke: A Multifactorial Approach." Frontiers in neuroscience vol. 14 473. 9 Jun. 2020.
For research use only, not for clinical use.
